US HEALTH SECRETARY KENNEDY SAYS NEW DRUG-PRICING DEALS INCLUDE $19.6BN IN COMMITMENTS TO RESHORE PHARMACEUTICAL PRODUCTION TO THE U.S.

NEW DEALS AIM TO LOWER DRUG PRICES FOR AMERICANS WHILE STRENGTHENING U.S. PHARMACEUTICAL SUPPLY CHAINS AND DOMESTIC MANUFACTURING.

متن اصلی؛ ترجمهٔ فارسی ندارد